The U.S. BIOSECURE Act aims to reduce U.S. reliance on Chinese biotechnology firms by 2032. The bill would have banned U.S. executive agenci...
About
Raghav Behani runs this blog in his personal capacity to document his thoughts on personal finance. No blog constitutes a BUY / SELL / HOLD recommendation and we avoid giving a price target and rating on any stock discussed. Raghav Behani was a SEBI registered Research Analyst till November 2021 only.